01.16.25 -- Can Our Current Operational Processes Survive In 2025 And Beyond?

Explore the exciting developments in continuous manufacturing and learn how leveraging this innovative technology can help improve manufacturing processes and discover new clinical candidates.

Watch to explore the relationship between a Contamination Control Strategy (CCS) and the development of a robust cleaning and disinfection program for cleanroom environments.

Gain insight into the development and validation of headspace methods for various product-container configurations with Dr. Derek Duncan and MSc, Josine Wilmer.

Late-stage clinical trial failures usually result in exposure with regard to capital equipment purchased to manufacture that product at a commercial scale. But what to do with this brand new, surplus equipment?

Ensure consistent planning, accurate cost estimation, and enhanced delivery timelines for materials shipped across borders by partnering with a CDMO equipped with a dedicated trade compliance team.

A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.

The oligonucleotide field is booming, but manufacturing challenges loom. Experts discuss optimizing production for these promising therapies with flexible, sustainable, and high-yield approaches.

Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.

Is your sterility testing process hindering your product release? Discover how the right approach can streamline your process, reduce false positives, and ultimately save you time and money.

Achieving high-quality drug product requires a combination of meticulous quality control measures, personnel expertise, and judicious application of technology — benefiting patients and the industry.

Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.

In many regulated labs, there is a need for reliable, robust HPLC systems capable of operating for extended periods of time to accommodate the demand for high instrument utilization and product timelines.

Gain insight into the most recent upgrades to Alconox's powder detergent packaging and the company's focus on continuous improvement from the Vice President of Strategy, Michael Moussourakis.